CLINICAL_TRIALS
trial_result
· 2023-08-23
Clinical Trial Update: Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension [Phase 4]
Summary
Phase 4 trial update showing sustained effect of droxidopa in symptomatic neurogenic orthostatic hypotension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Symptomatic Neurogenic Orthostatic Hypotension | Phase 4 | Status: COMPLETED | Results posted: 2023-08-23